News | Press Releases

---

November 25, 2018

Canon Medical Systems Launches New Line of Interventional Systems at RSNA 2018

The Alphenix Systems Feature All-New Hi-Def Imaging Detector with Highest Resolution in the Market to Help Clinicians See Fine Details

CHICAGO, Nov. 25, 2018 – Canon Medical Systems USA, Inc. is ushering in a new era of innovation in interventional imaging by introducing its next-generation of interventional systems – the Alphenix platform. The new flagship platform of systems incorporates all-new features that enable clinicians to deliver images with clarity and precision without compromising workflow and while prioritizing low dose.

With the launch of the Alphenix family, Canon Medical is also unveiling its exclusive new Alphenix Hi-Def Detector (High-Definition Flat Panel Detector), which is available on the all-new Alphenix Biplane and Alphenix Core + systems. Made up of the world’s first high-definition detector – with 76 micron resolution – for resolving fine details, the unique hybrid 12″ x 12″ panel is combined with high-definition flat panel technology that results in resolutions of 2.6 lp/mm (Standard) and 6.6 lp/mm (Hi-Def Detector). The Alphenix Hi-Def Detector technology helps clinicians see finer details during complex interventional procedures such as stent positioning and stent apposition, wire and catheter navigation through the stent struts, and observation of coil deployment.

In addition to the new Alphenix Hi-Def Detector, the Alphenix family includes the following new features:

• Next generation Illuvis technology to reduce image noise with less lag time, and provide clearer images at steep angles while delivering a decreased frame rate that can help reduce dose
• Real-Time Auto-Pixel Shift to automatically correct misalignment between the contrast image and mask image during digital subtraction angiography and 2D roadmapping utilization
• (Optional) Tablet touch screen to optimize tableside workflow with simplified control functions and the option to assign “favorites” to customize the interface, per physician

“Canon Medical is redefining what is possible in intervention with the launch of the Alphenix family,” said Casey Waldo, director, Vascular Business Unit, Canon Medical Systems USA, Inc. “With the highest level of resolution available in the angiography market, our customers now have the ability to perform minimally invasive procedures with clear images to see fine details, enabling them to prioritize clinical decisions and patient outcomes.”

Canon Medical is showcasing the new Alphenix and Alphenix Hi-Def Detector technology, available with the Alphenix Biplane and Alphenix Core + systems, at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, IL from November 25-30, 2018 (Booth #1938, South Level 3).

About Canon Medical Systems USA, Inc.

Canon Medical Systems USA, Inc., headquartered in Tustin, Calif., markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and interventional X-ray equipment. For more information, visit Canon Medical Systems’ website at https://us.medical.canon.

About Canon Medical Systems Corporation

Canon Medical Systems Corporation develops and manufactures diagnostic imaging systems including CT, MRI, ultrasound, X-ray systems and clinical laboratory systems and provides them to around 140 countries and regions around the world, offering technology that provides faster diagnosis and early treatment. Under the slogan “Made for Life” (Made for Partnerships, Made for Patients, Made for You.), Canon Medical Systems is making positive contributions toward hospital management, and provides a range of patient-friendly healthcare systems and services, continuing its long tradition of contributing to healthcare.